Literature DB >> 2759933

Extended spectrum cephalosporins and Clostridium difficile.

C L Golledge1, T McKenzie, T V Riley.   

Abstract

There is little information about how commonly the newer cephalosporins cause diarrhoea due to Clostridium difficile. In this study of 111 patients with C. difficile-associated diarrhoea, 106 had received antimicrobial agents in the four weeks before detection of C. difficile. The relative risk for each antimicrobial agent was greatest with clindamycin, followed by cefotaxime, cephamandole and ceftriaxone. There was no statistically significant difference in risk between the cephalosporins evaluated. Narrower spectrum penicillins, anti-pseudomonal penicillins and aminoglycosides were not potent inciting agents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2759933     DOI: 10.1093/jac/23.6.929

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

Review 1.  Antibiotic-associated diarrhoea. A costly problem.

Authors:  T V Riley
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

2.  Clostridium difficile: a pathogen of the nineties.

Authors:  T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

3.  Treatment of acute uncomplicated urinary tract infection with ceftibuten.

Authors:  G E Stein; S Christensen; N Mummaw
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

4.  Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime.

Authors:  M Impallomeni; N P Galletly; S J Wort; J M Starr; T R Rogers
Journal:  BMJ       Date:  1995-11-18

Review 5.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 6.  Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.

Authors:  G L Kearns; R A Young
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

Review 7.  Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.

Authors:  Masako Mizusawa; Shira Doron; Sherwood Gorbach
Journal:  Drugs Aging       Date:  2015-08       Impact factor: 3.923

8.  Clostridium difficile-associated diarrhoea: epidemiological data from Western Australia.

Authors:  T V Riley; G L O'Neill; R A Bowman; C L Golledge
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.